“The week”: Focus on financing costs

• 

  Karin Beerli
  Kreation & Media

Switzerland

Shares of Western Swiss fragrance specialist Givaudan (Ticker: GIVN SW) are finally flashing green on the Swiss stock exchange: up 24.44% since the turn of the year. Step by step, the financial metrics of the CHF 36.14 billion stock continue to improve. According to the underlying models, book value per share could improve from CHF 432.4 to CHF 655.8 between 2023 and 2028. The payout per share could rise from CHF 68 to CHF 78.8, which would make an annual reinvestment of the dividend into new shares worthwhile.
Trading strategy: Reload

Thanks to a significantly improved positioning, shares of Winterthur-based flagship company Sulzer (Ticker: SUN SW) are once again gaining investor confidence, a development attributed to the company’s smart strategic direction. Operating income (EBIT) could rise from CHF 329.9 million to CHF 414.3 million between 2023 and 2028, which would make an annual reinvestment of the dividend into new shares worthwhile.
Trading strategy: Reload

Shares of new SMI stock Galderma (Ticker: GALD SW) have picked up pace in recent days: up 8.61% since the turn of the year. The background would be a marked improvement in the expected book value per share from USD 32.81 to USD 49.06 between 2024 and 2028, which would make the share price development of recent months at this CHF 41.05 billion stock more comprehensible.
Trading strategy: Reload

Shares of insulin pen specialist Ypsomed (Ticker: YPSN SW) have shown a positive development for some time: up 15.12% since the turn of the year. An improvement in book value per share is projected between 2023 and 2028, from CHF 45.26 to CHF 94.72. With an expected return on equity of 19.64% by 2028, first signs of improvement would be emerging.
Trading strategy: Reload

Europe:

Shares of Finnish pharmaceutical stock Orion (Ticker: ORNBV FH) are seeing a marked upswing: since the start of the year, the stock has risen 37.78%, an extremely strong result by European standards. According to current analyses, operating income could improve from EUR 274.9 million to EUR 945.3 million between 2023 and 2028, which would be highly significant. Earnings per share could also rise from EUR 1.54 to EUR 5.374, which would make an investment more attractive going forward.
Trading strategy: Reload

Spanish information technology specialist Indra Sistemas (Ticker: IDR SM) is presenting itself as an excellently positioned stock for the first time in a while: in the current year 2026 alone, the share has gained 31.19%, a very strong result compared with the return of its home market index. Book value per share could improve from EUR 6.413 to EUR 18.6 between 2023 and 2028. The expected EBIT margin would stand at 11.28% in 2028, which would be a good figure for the company by historical comparison, with a reinvestment of the dividend into new shares also worth considering, given that this strategy has proven very successful for this stock over a period of 5 years. Dividend per share could rise from EUR 0.25 to EUR 0.4884 between 2023 and 2028.
Trading strategy: Reload

Shares of Netherlands-based insurer ASR Nederland (Ticker: ASRNL NA) continue to trend steadily upward: up 22.17% since the turn of the year. An increase in earnings per share is projected between 2023 and 2028, from EUR 5.26 to EUR 7.277. By 2028, a record dividend payout per share of EUR 4.526 is projected for this EUR 14.93 billion stock.
Trading strategy: Reload

Shares of Belgian insurance specialist Ageas (Ticker: AGS BB) are considered attractive, with the upward trend expected to continue through the end of 2028. Earnings per share at this EUR 15.52 billion stock could rise significantly from EUR 5.179 to EUR 8.755 between 2023 and 2028.
Trading strategy: Reload

US/CAN:

Previously featured CF Industries (Ticker: CF US) continues to be considered a stock with major potential on the more speculative side. Book value per share at this USD 18.29 billion stock could improve from USD 29.58 to USD 54.56 between 2023 and 2028, which would represent an enormous increase.Trading strategy: Reload

Conservatively oriented investors are backing commodity specialist ConocoPhillips (Ticker: COP US). At this USD 176 billion stock, book value per share could increase from USD 41.83 to USD 64.26 between 2023 and 2028. With an EBIT margin of 27% in 2028, the outlook would appear reassuring.Trading strategy: Reload

Shares of supply chain software specialist Manhattan Associates (Ticker: MANH US) are developing dynamically on the stock market this year. An increase in operating income from USD 281.5 million to USD 508 million is projected between 2023 and 2028. The EBIT margin could reach a new record of 36.91% in 2028, which would represent a very good figure for this sector.
Trading strategy: Reload

Wall Street high-flyer McKesson (Ticker: MCK US) ranks among the particularly interesting stocks on the market. Operating income at this USD 117 billion stock could rise from USD 4.901 billion to USD 8.317 billion between 2024 and 2029, which would underpin the company’s successful strategic direction. However, the dividend yield remains very low for the foreseeable future.
Trading strategy: Reload

Shares of convenience store operator Casey’s General Stores (Ticker: CASY US) rank among the particularly interesting stocks on the market. Earnings per share at this USD 25.47 billion stock could rise from USD 13.43 to USD 26.22 between 2023 and 2028. With a record dividend per share of USD 3.07 in 2028, the overall picture would appear compelling – a stock with a multi-year outlook.
Trading strategy: Reload

Yours sincerely,
François Bloch

____

Investment idea of the week

____

Today at 5:00 p.m.: “Bloch Live”

Look forward to a lively conversation between two experts, fascinating topics, and candid opinions.

Be there!

___

Disclaimer
Lucht Probst Associates AG and François Bloch do not receive any payments or commissions from the products mentioned.